Mesangial cell apoptosis induced by stimulation of the adenosine A3 receptor: signaling and apoptotic events

J Investig Med. 2005 Jan;53(1):37-43. doi: 10.2310/6650.2005.00004.

Abstract

Mesangial cell apoptosis has been proposed as a means of resolution of glomerular hypercellularity in proliferative forms of glomerular disease. We previously demonstrated that adenosine causes mesangial cell apoptosis by stimulating the A3-type adenosine receptor. This is a G protein-coupled receptor shown to activate kinases involved in apoptotic signaling. In this work, we assessed changes in phosphorylation of the mitogen-activated protein kinase extracellular signal-regulated kinase (ERK)1/2 and in levels of specific pro- and antiapoptotic proteins following exposure of mesangial cells to the A3 adenosine receptor agonist N(6)-(3-iodobenzyl)-adenosine-5'-N-methyluronamide (IB-MECA). Cultured mesangial cells were incubated with IB-MECA for 30 minutes and 6, 24, and 48 hours. IB-MECA was used at a concentration (30 microM) that induces a reproducible degree of mesangial cell apoptosis. Changes in ERK1/2 phosphorylation and in protein levels of Bcl-2, Bax, and caspase 3 were assessed by Western blot analysis. IB-MECA markedly increased phosphorylation of ERK1/2. This effect peaked at 5 minutes, dissipated by 20 minutes, and was abolished by the inhibitor of ERK phosphorylation, compound U0126, in a dose-dependent manner. This inhibitor had no effect on the extent of IB-MECA-induced apoptosis. Bcl-2 levels progressively declined, whereas those of Bax and activated caspase 3 increased. These observations indicate that stimulation of the A3-type adenosine receptor causes mesangial cell apoptosis via mechanisms independent of ERK activation. The observations also point to an imbalance in the expression of antiapoptotic (Bcl-2) and proapoptotic (Bax, caspase 3) proteins as a potential mechanism underlying adenosine-induced mesangial cell apoptosis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenosine / analogs & derivatives*
  • Adenosine / pharmacology
  • Animals
  • Apoptosis* / drug effects
  • Butadienes / pharmacology
  • Caspase 3
  • Caspases / metabolism
  • Cell Line, Transformed
  • Dose-Response Relationship, Drug
  • Drug Combinations
  • Enzyme Inhibitors
  • Glomerular Mesangium / drug effects
  • Glomerular Mesangium / pathology*
  • Mice
  • Mitogen-Activated Protein Kinase 1 / antagonists & inhibitors
  • Nitriles / pharmacology
  • Phosphorylation
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Receptor, Adenosine A3 / drug effects
  • Receptor, Adenosine A3 / metabolism*
  • Signal Transduction* / drug effects
  • bcl-2-Associated X Protein

Substances

  • Bax protein, mouse
  • Butadienes
  • Drug Combinations
  • Enzyme Inhibitors
  • Nitriles
  • Proto-Oncogene Proteins c-bcl-2
  • Receptor, Adenosine A3
  • U 0126
  • bcl-2-Associated X Protein
  • N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine
  • Mitogen-Activated Protein Kinase 1
  • Casp3 protein, mouse
  • Caspase 3
  • Caspases
  • Adenosine